The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABIOMED INC | COMMON | 003654100 | 28,330 | 251,416 | SH | SOLE | 120,316 | 0 | 131,100 | ||
ACADIA HEALTHCARE | COMMON | 00404A109 | 29,340 | 886,405 | SH | SOLE | 449,305 | 0 | 437,100 | ||
ACADIA PHARMACEUTICALS | COMMON | 004225108 | 33,932 | 1,176,543 | SH | SOLE | 641,607 | 0 | 534,936 | ||
ACCELERON PHARMA | COMMON | 00434H108 | 8,810 | 345,225 | SH | SOLE | 84,125 | 0 | 261,100 | ||
ACCURAY INC | COMMON | 004397105 | 14,134 | 3,072,536 | SH | SOLE | 1,151,008 | 0 | 1,921,528 | ||
ADVAXIS INC | COMMON | 007624208 | 4,941 | 690,074 | SH | SOLE | 190,251 | 0 | 499,823 | ||
AERIE PHARMACEUTICALS | COMMON | 00771V108 | 8,906 | 235,298 | SH | SOLE | 67,998 | 0 | 167,300 | ||
AETNA INC | COMMON | 00817Y108 | 22,593 | 182,185 | SH | SOLE | 115,485 | 0 | 66,700 | ||
AGIOS PHARMACEUTICALS | COMMON | 00847X104 | 2,291 | 54,900 | SH | SOLE | 54,900 | 0 | 0 | ||
ALDER BIOPHARMACEUTICALS | COMMON | 014339105 | 13,923 | 669,351 | SH | SOLE | 288,151 | 0 | 381,200 | ||
ALNYLAM PHARMACEUTICALS | COMMON | 02043Q107 | 745 | 19,899 | SH | SOLE | 19,899 | 0 | 0 | ||
AMICUS THERAPEUTICS | COMMON | 03152W109 | 25,348 | 5,100,198 | SH | SOLE | 2,980,973 | 0 | 2,119,225 | ||
AVEXIS INC | COMMON | 05366U100 | 1,108 | 23,215 | SH | SOLE | 23,215 | 0 | 0 | ||
BIOGEN INC | COMMON | 09062X103 | 24,059 | 84,841 | SH | SOLE | 55,741 | 0 | 29,100 | ||
BIOMARIN PHARMACEUTICAL INC | COMMON | 09061G101 | 40,766 | 492,100 | SH | SOLE | 371,303 | 0 | 120,797 | ||
CELGENE CORP | COMMON | 151020104 | 50,233 | 433,981 | SH | SOLE | 315,081 | 0 | 118,900 | ||
CIGNA CORP | COMMON | 125509109 | 28,335 | 212,424 | SH | SOLE | 145,524 | 0 | 66,900 | ||
COLLEGIUM PHARMACEUTICAL | COMMON | 19459J104 | 32,771 | 2,104,756 | SH | SOLE | 1,120,251 | 0 | 984,505 | ||
DBV TECHNOLOGIES | SP ADR | 23306J101 | 1,349 | 38,401 | SH | SOLE | 38,401 | 0 | 0 | ||
DEXCOM INC | COMMON | 252131107 | 30,437 | 509,836 | SH | SOLE | 261,701 | 0 | 248,135 | ||
DR REDDYS LABS LTD | ADR | 256135203 | 1,456 | 32,155 | SH | SOLE | 32,155 | 0 | 0 | ||
ELI LILLY & CO | COMMON | 532457108 | 53,627 | 729,117 | SH | SOLE | 500,117 | 0 | 229,000 | ||
ENTELLUS MED INC | COMMON | 29363K105 | 2,476 | 130,496 | SH | SOLE | 0 | 0 | 130,496 | ||
ENVISION HEALTHCARE | COMMON | 29414D100 | 7,914 | 125,040 | SH | SOLE | 140 | 0 | 124,900 | ||
GLOBAL BLOOD THERAPEUTICS | COMMON | 37890U108 | 16,268 | 1,125,801 | SH | SOLE | 513,805 | 0 | 611,996 | ||
INCYTE CORPORATION | COMMON | 45337C102 | 3,447 | 34,374 | SH | SOLE | 34,374 | 0 | 0 | ||
INSMED INC | COMMON | 457669307 | 1,367 | 103,300 | SH | SOLE | 103,300 | 0 | 0 | ||
INTEGRA LIFESCIENCE | COMMON | 457985208 | 5,937 | 69,200 | SH | SOLE | 0 | 0 | 69,200 | ||
INTERCEPT PHARMACEUTICALS | COMMON | 45845P108 | 8,056 | 74,150 | SH | SOLE | 7,125 | 0 | 67,025 | ||
INTERSECT ENT INC | COMMON | 46071F103 | 6,473 | 534,937 | SH | SOLE | 342,097 | 0 | 192,840 | ||
INTUITIVE SURGIC INC | COMMON | 46120E602 | 26,899 | 42,416 | SH | SOLE | 29,858 | 0 | 12,558 | ||
K2M GROUP HOLDINGS | COMMON | 48273J107 | 3,115 | 155,450 | SH | SOLE | 250 | 0 | 155,200 | ||
KITE PHARMA INC | COMMON | 49803L109 | 16,690 | 372,223 | SH | SOLE | 176,503 | 0 | 195,720 | ||
MERCK & CO INC | COMMON | 58933Y105 | 57,329 | 973,832 | SH | SOLE | 673,932 | 0 | 299,900 | ||
MOLINA HEALTHCARE | COMMON | 60855R100 | 7,425 | 136,845 | SH | SOLE | 245 | 0 | 136,600 | ||
MOMENTA PHARMACEUTICALS | COMMON | 60877T100 | 5,711 | 379,500 | SH | SOLE | 800 | 0 | 378,700 | ||
NEUROCRINE BIOSCIENCES | COMMON | 64125C109 | 28,986 | 748,988 | SH | SOLE | 349,588 | 0 | 399,400 | ||
NEURODERM LTD | ORD SHS | M74231107 | 9,786 | 440,799 | SH | SOLE | 440,799 | 0 | 0 | ||
NOVO-NORDISK AS | ADR | 670100205 | 8,477 | 236,380 | SH | SOLE | 236,380 | 0 | 0 | ||
NUVASIVE INC | COMMON | 670704105 | 33,592 | 498,689 | SH | SOLE | 208,989 | 0 | 289,700 | ||
NXSTAGE MEDICAL | COMMON | 67072V103 | 23,361 | 891,313 | SH | SOLE | 346,057 | 0 | 545,256 | ||
PFIZER INC | COMMON | 717081103 | 57,306 | 1,764,343 | SH | SOLE | 1,215,343 | 0 | 549,000 | ||
PORTOLA PHARMACEUTICALS | COMMON | 737010108 | 31,851 | 1,419,404 | SH | SOLE | 692,362 | 0 | 727,042 | ||
PROFOUND MEDICAL | COMMON | 74319B106 | 414 | 495,900 | SH | SOLE | 495,900 | 0 | 0 | ||
PRONAI THERAPEUTICS | COMMON | 074346L10 | 367 | 201,660 | SH | SOLE | 201,660 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 6,082 | 123,646 | SH | SOLE | 23,646 | 0 | 100,000 | ||
PTC THERAPEUTICS I | COMMON | 69366J200 | 1,343 | 123,135 | SH | SOLE | 123,135 | 0 | 0 | ||
RA PHARMACEUTICALS | COMMON | 74933V108 | 3,842 | 252,940 | SH | SOLE | 105,500 | 0 | 147,440 | ||
SAGE THERAPEUTICS | COMMON | 78667J108 | 1,425 | 27,899 | SH | SOLE | 27,899 | 0 | 0 | ||
SAREPTA THERAPEUTICS | COMMON | 803607100 | 790 | 28,799 | SH | SOLE | 28,799 | 0 | 0 | ||
SHIRE PLC | SP ADR | 82481R106 | 26,947 | 158,158 | SH | SOLE | 158,158 | 0 | 0 | ||
SURGICAL CARE AFFILIATES | COMMON | 86881L106 | 4,548 | 98,300 | SH | SOLE | 0 | 0 | 98,300 | ||
TELADOC INC | COMMON | 87918A105 | 25,903 | 1,569,878 | SH | SOLE | 754,900 | 0 | 814,978 | ||
TRILLIUM THERAPEUTICS | COMMON | 89620X506 | 565 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
WRIGHT MED GROUP N V | ORD SHS 0.03 PAR | N96617118 | 10,547 | 458,977 | SH | SOLE | 305 | 0 | 458,672 |